Dec 23, 2025 • Finviz
NEUTRAL
3 Reasons NSP is Risky and 1 Stock to Buy Instead
Insperity (NSP) has seen a significant stock drop and raises concerns due to lackluster revenue growth, declining earnings per share (EPS), and a dropping free cash flow margin. StockStory analysts recommend caution with NSP and suggest looking into an aerospace business with a strong M&A strategy, or other "High Quality" stocks from their curated list, as better investment opportunities.
Dec 21, 2025 • MarketBeat
BEARISH
Insperity, Inc. (NYSE:NSP) Given Consensus Recommendation of "Reduce" by Analysts
Insperity, Inc. (NYSE:NSP) has received a consensus "Reduce" rating from analysts, with a target price of $46.67, following recent downgrades and price target cuts by firms like Truist and JPMorgan. The company missed its last quarterly earnings and revenue expectations and despite offering a high dividend yield of 6.2%, its payout ratio is concerningly high at 521.74%. Insider activity shows a director bought shares, while institutional investors have adjusted their positions in the stock.
Dec 20, 2025 • Sahm
SOMEWHAT-BULLISH
Insperity (NSP): Reassessing Valuation After Expanded Credit Facility and Extended Maturity Terms
Insperity (NSP) recently expanded its credit facility to $750 million with maturity extended to 2028, providing greater financial flexibility. While the company's valuation is seen as undervalued with a fair value of $45 based on its HRScale initiative, its high P/E ratio of 85.6 raises concerns about overvaluation if growth falters. Investors should consider both the potential for recovery and the risks associated with healthcare cost inflation and slower-than-expected HRScale adoption.
Dec 19, 2025 • Sahm
SOMEWHAT-BULLISH
Is Insperity’s (NSP) Bigger Credit Line Quietly Rewriting Its Long-Term Capital Strategy?
Insperity recently expanded its revolving credit facility to $750 million and relaxed covenant terms, providing more flexibility for operations, technology investments, and growth initiatives. This move offers Insperity additional room to maneuver without immediate balance sheet constraints, especially if SMB hiring and margins take longer to recover. While the increased liquidity is supportive, investors should still consider how rising healthcare and benefits costs could impact margins and earnings.
Dec 18, 2025 • The Globe and Mail
NEUTRAL
Insperity Expands Credit Facility with Amegy Bank
Insperity Inc. announced an expansion to its credit facility with Amegy Bank, increasing its revolving credit capacity from $650 million to $750 million with a potential for $800 million. This amendment also extends the maturity date to December 15, 2028, enhancing Insperity’s financial flexibility. Despite strong revenue growth, analysis suggests Insperity faces profitability and leverage challenges, with a "Neutral" rating from TipRanks' AI Analyst Spark.
Dec 17, 2025 • Business Wire
BULLISH
Insperity Named to Inc.’s 2025 Best in Business List in the Best Customer Service and Best Community Initiatives Categories
Insperity, Inc. has been recognized by Inc. on its 2025 Best in Business list in the Best Customer Service and Best Community Initiatives categories. The recognition specifically highlights Insperity’s North Star Network (NSN) thought leadership program for its impact on the human resources industry by providing research-driven insights and guidance to navigate workforce challenges. Paul Sarvadi, Insperity's chairman and CEO, emphasized the value of the North Star Network in empowering leaders to address challenges and elevate performance.